Basilea Pharma names Ditzinger as CTO; Ghana offering pharma technology training; Halo names new CEO, CFO;

> Basilea Pharmaceutica ($BSLN) has named Dr. Günter Ditzinger to succeed Dr. Heinze-Krauss as chief technology officer effective Feb. 1, 2016. Ditzinger also was named a member of the management committee. More

> The National Vocational Training Institute of Ghana is teaming with a German development agency to offer a pharmaceutical manufacturing technology program for qualified applicants. Story

> New Jersey-based Halo Pharmaceutical, a CDMO, has named Lee Karras as its new CEO, and Barry Lederman as its CFO. Announcement

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.